Takeda and IDT Biologika to Manufacture J&J’s COVID-19 Vaccine

The companies will use capacity at IDT previously reserved for Takeda’s dengue vaccine candidate, TAK-003, to manufacture Janssen Pharmaceutical’s single-shot COVID-19 vaccine.